How we treat febrile neutropenia in patients receiving cancer chemotherapy.

Publication Type:

Journal Article

Source:

Journal of oncology practice / American Society of Clinical Oncology, Volume 6, Issue 3, p.149-52 (2010)

Abstract:

Although improved supportive care has reduced mortality associated with febrile neutropenia, it continues to cause chemotherapy limitations, morbidity, mortality, and cost among patients with cancer.